zoledronic acid has been researched along with Hypophosphatemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, Y; Katsunuma, R; Mitsumoto, K; Mizumoto, A; Nakauchi, C; Uzu, T | 1 |
| Karpiłowska, A; Podgórska, J; Popow, M; Radziszewski, M; Ziółkowska, A | 1 |
| Sözel, H; Yilmaz, F | 1 |
| Conca, P; Di Minno, G; Matani, B; Rendina, D; Tufano, A | 1 |
| Bernstein, M; Fan, TM; Goldsby, RE; Gorlick, R; Isakoff, MS; Kim, G; Krailo, M; Lee, S; Marina, N; Meyer, J; Randall, RL; Villaluna, D; Wagner, LM | 1 |
| Cheung, MS | 1 |
| George, S; Hummel, K; Kaplan, P; Levine, MA; Monk, HM; Weber, DR | 1 |
| Clark, SL; Nystrom, EM | 1 |
| Chakrabarti, SS; Gambhir, IS; Kaur, U | 1 |
1 review(s) available for zoledronic acid and Hypophosphatemia
| Article | Year |
|---|---|
Drugs Used in Paediatric Bone and Calcium Disorders.
Topics: Acetazolamide; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Calcitriol; Calcium; Child; Denosumab; Diphosphonates; Diuretics; Glucocorticoids; Humans; Hypercalcemia; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Imidazoles; Osteoporosis; Parathyroid Hormone; Phosphates; Risedronic Acid; Sodium Potassium Chloride Symporter Inhibitors; Vitamin D; Zoledronic Acid | 2015 |
1 trial(s) available for zoledronic acid and Hypophosphatemia
| Article | Year |
|---|---|
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; Extremities; Feasibility Studies; Female; Humans; Hypokalemia; Hyponatremia; Hypophosphatemia; Imidazoles; Kaplan-Meier Estimate; Male; Mucositis; Neoplasm Metastasis; Osteosarcoma; Pain; Treatment Outcome; Young Adult; Zoledronic Acid | 2013 |
7 other study(ies) available for zoledronic acid and Hypophosphatemia
| Article | Year |
|---|---|
Fanconi Syndrome Associated with Long-term Treatment with Zoledronate.
Topics: Aged, 80 and over; Diphosphonates; Fanconi Anemia; Fanconi Syndrome; Female; Humans; Hypophosphatemia; Osteomalacia; Zoledronic Acid | 2023 |
Life-threatening hypophosphataemia secondary to zoledronic acid implementation in a middle-age patient who presented with advanced osteolysis in the course of multiple myeloma.
Topics: Bone Density Conservation Agents; Humans; Hypophosphatemia; Male; Middle Aged; Multiple Myeloma; Osteolysis; Zoledronic Acid | 2020 |
Symptomatic hypocalcemia following a single dose of zoledronic acid in a patient with bone metastases secondary to breast cancer.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Hypocalcemia; Hypophosphatemia; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Vitamin D Deficiency; Zoledronic Acid | 2021 |
Hypocalcemia and hypophosphatemia after treatment with zoledronic acid in a patient with AL amyloidosis.
Topics: Administration, Intravenous; Bone Density Conservation Agents; Fatigue; Humans; Hypocalcemia; Hypophosphatemia; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Zoledronic Acid | 2019 |
Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience.
Topics: Acute-Phase Reaction; Adolescent; Alkaline Phosphatase; Bone Density Conservation Agents; Bone Diseases; Calcitriol; Calcium; Child; Child, Preschool; Diphosphonates; Female; Humans; Hypercalcemia; Hypocalcemia; Hypophosphatemia; Imidazoles; Infant; Male; Osteogenesis Imperfecta; Osteoporosis; Prospective Studies; Retrospective Studies; Risk Factors; Young Adult; Zoledronic Acid | 2015 |
A Case of Severe, Prolonged, Refractory Hypophosphatemia After Zoledronic Acid Administration.
Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Hypercalcemia; Hypophosphatemia; Imidazoles; Male; Middle Aged; Paraneoplastic Syndromes; Zoledronic Acid | 2016 |
Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Humans; Hypocalcemia; Hypophosphatemia; Imidazoles; Male; Osteoporosis; Zoledronic Acid | 2016 |